Immunicum’s ilixadencel successful in kidney cancer
The drug achieved complete tumour responses in five out of 45 metastatic kidney cancer patients, compared to one in 25.
Read More
Tag: MONOTHERAPY
Sanofi, Regeneron successful in phase II asthma trial
The investigational IL-33 antibody REGN3500 met its primary and secondary endpoints in the joint phase II proof-of-concept trial.
Read More
Positive late stage rheumatoid arthritis trial results for Abbvie
Upadacitinib was found to have achieved both primary endpoints with significantly higher rates of ACR20 response and low disease activity at week 14.
Read More
MSD’s Keytruda bags another trial success in NSCLC
MSD’s Keytruda has significantly increased overall survival in patients with lung cancer expressing any level of PD-L1 when used as monotherapy in the first-line setting, potentially significantly increasing the drug’s treatment scope.
Read More
AZ’ Lynparza delays ovarian cancer progression, data show
A twice-daily dose of AstraZeneca’s Lynparza held off progression of ovarian cancer in certain patients when used as a maintenance treatment during a late-stage trial.
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
